Neutrophil-Lymphocyte Ratio and its Association with Hyperglycaemia: A Cross Sectional Study

Authors

  • Shailendra Dandge MD, Professor, Department of Pharmacology, SHARE INDIA-MediCitiInstitute of Medical Sciences, India.
  • B. Pooja Shivani Mediciti Institute of Medical Sciences

DOI:

https://doi.org/10.5195/ijms.2022.1800

Keywords:

Neutrophil-lymphocyte ratio, Prediabetes, Type 2 diabetes mellitus, Glycaemic control

Abstract

Introduction: Chronic subclinical inflammation indicated by an elevated neutrophil-lymphocyte ratio (NLR) calculated from a complete blood count (CBC) test is reported to be associated with hyperglycaemia, including prediabetes and type 2 diabetes mellitus (T2DM). Current evidence on the association between NLR and glycaemic status is limited and conflicting.

AIM: To determine if NLR was higher in those with prediabetes compared to those with normoglycemia, and To compare the NLR among individuals on treatment for T2DM stratified by glycaemic control.

Methods: We analysed hospital data of individuals attending a tertiary care hospital in south India between January, 2021 and December, 2021. Individuals had CBC and glycosylated haemoglobin (HbA1c) tests done at the same visit. Hospital records of only those individuals without any clinical features of inflammation at the time of hospital visit were included in this analysis. Normoglycemia and prediabetes were defined as HbA1c < 5.7% and HbA1c ≥5.7 but ≤6.4% respectively, in those without a history of T2DM. Good glycaemic control and poor glycaemic control were defined as HbA1c<7% and HbA1c ≥7 respectively in those on treatment for T2DM.CBC and HbA1c data of 109 individuals each with normoglycemia and prediabetes; and 373 individuals on treatment for T2DM were analysed.  After confirming the normality of distribution of NLR, unpaired Student’s ‘t’ test was used: 1. to compare the NLR between those with normoglycemia and prediabetes and 2. to compare NLR among those on treatment for T2DM stratified by glycaemic control.

Results: Demographic characteristics including mean age and sex ratio among individuals with and without prediabetes were similar. The Mean (SD) NLR was higher in those with prediabetes compared to those with normoglycemia 1.7(1.0) versus 1.4(0.3); p=0.002. Of the 373 individuals on treatment for T2DM,121(32.4%) had good glycaemic control. There were no differences in demographic characteristics of those with and without good glycaemic control. The mean (SD) NLR between those with and without good glycaemic control, respectively was not different; 1.6(0.1) versus 1.7(0.1); p=0.46.

Conclusion: In individuals without any clinical features of inflammation, a higher neutrophil-lymphocyte ratio was associated prediabetes. However, there was no association between neutrophil-lymphocyte ratio and glycaemic control among those on treatment for T2DM.

 

Metrics

Metrics Loading ...

Downloads

Published

2022-12-31 — Updated on 2023-03-06

Versions

How to Cite

Dandge, S., & Pooja Shivani, B. (2023). Neutrophil-Lymphocyte Ratio and its Association with Hyperglycaemia: A Cross Sectional Study. International Journal of Medical Students, 10, S218. https://doi.org/10.5195/ijms.2022.1800 (Original work published December 31, 2022)

Issue

Vol 10 (2022): Supplement 1

Section

Abstracts of the WCMSR

License

Copyright (c) 2022 Shailendra Dandge, B. PoojaShivani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org